Europe Non-Invasive Aesthetic Treatment Market Growth and Forecast by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Europe Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Procedure (Injectables, Skin Rejuvenation, and Others) and End User (Hospitals, Clinics and Medical Spas, and Others)

  • Report Date : Jul 2021
  • Report Code : TIPRE00023341
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 151
Page Updated: Jul 2021

The Europe non-invasive aesthetic treatment market is expected to reach US$ 5,830.17 million by 2028 from US$ 2,337.83 million in 2021, it is estimated to grow at a CAGR of 13.9% from 2021 to 2028.



The growth of the market is attributed to a few key driving factors such as surging awareness about cosmetic procedures among consumers and availability of technologically advanced products. However, clinical risks and complications associated with medical aesthetic procedures are hindering the market growth.

Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their noninvasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Moreover, non-invasive treatments are gaining traction due to high preference for less downtime post treatment. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people. For example, the government in England began a campaign in 2019 on botched cosmetic procedures and their influence on a person’s physical and mental health. Therefore, the growing awareness regarding non-invasive aesthetic treatment procedures is boosting the growth of the Europe non-invasive aesthetic treatment market. Several manufacturers are working on advanced non-invasive aesthetic treatment products. Therefore, the availability of user-friendly, technologically advanced non-invasive aesthetic treatment products is fuelling the market growth.

The COVID-19 pandemic has slightly hindered the medical device industry in Europe. Various companies have shut down their productions; hence, they are unable to meet the rising demand. The routine health care services have remained suspended. On the other hand, the number of COVID-19 confirmed cases has grown significantly, and it has raised the question regarding safety from the aesthetic treatments done by lasers and micro-needling. Thus, aesthetic services have been shut down in European countries. Hence, it is expected that the negative impact on the Europe non-invasive aesthetic treatment market will continue in the following a few years.

22995-img1
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
 

EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET SEGMENTATION

By Procedure

  • Injectables
    • Botulinum Toxin
    • Calcium Hydroxylapatite
    • Hyaluronic Acid
    • Polymer Filler
    • Collagen
  • Skin Rejuvenation
    • Chemical Peel
    • Laser Skin Resurfacing
    • Photorejuvenation
  • Others
    • Hair Removal
    • Nonsurgical Fat Reduction
    • Sclerotherapy
    • Cellulite Treatment

By End User

  • Hospitals
  • Clinics and Medical Spas
  • Others

By Country

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

Company Profiles

  • Galderma
  • Alma Lasers
  • Merz Pharma
  • Bausch Health Companies Inc.
  • Cutera Inc.
  • AbbVie Inc.
  • Candela Medical
  • Johnson and Johnson Services, Inc.

Europe Non-Invasive Aesthetic Treatment Report Scope

Report Attribute Details
Market size in 2021 US$ 2,337.83 Million
Market Size by 2028 US$ 5,830.17 Million
Global CAGR (2021 - 2028) 13.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Procedure
  • Injectables
  • Skin Rejuvenation
By End User
  • Hospitals
  • Clinics and Medical Spas
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Galderma
  • Alma Lasers
  • Merz Pharma
  • Bausch Health Companies Inc.
  • Cutera Inc.
  • AbbVie Inc.
  • Candela Medical
  • Johnson and Johnson Services, Inc.
  • Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo